ABOUT US

Innovating at the speed of AI

The world has undergone a rapid and transformative shift since the adoption of AI. This is particularly evident in biopharma, where the possibility of a truly ground-breaking solution that accelerates research, disease diagnosis and trial-matching is at hand.

We’ve assembled an exceptional team to do just that, comprised of individuals with an indisputable track record of excellence.

Meet the team

Simon Arkell

Co-Founder & CEO

Read more Close

Simon is a hi tech entrepreneur and investor with a focus on AI and healthcare technology. Co-founder of 7 venture backed companies, including Deep Lens, Predixion Software and Versifi, which together raised over $100M in venture backing. All three were acquired.

Alex Dickinson

Co-Founder & Chairman

Read more Close

Co-founder/Chair/CEO: ChromaCode (COVID XPrize winner); Helixis (acquired by Illumina) and Luxtera (acquired by Cisco). Board member Gencove (low pass sequencing) and previously PRA Health Sciences (public, acquired by ICON). Seven year Illumina SVP (led BaseSpace and PopSeq businesses). Began career in research at Bell Labs; co-inventor of the CMOS fingerprint sensor.

Chadi Nabhan

Chief Medical Officer & Head of Strategy

Read more Close

Dr. Chadi Nabhan is the Chief Medical Officer and Head of Strategy at Ryght, bringing over 20 years of oncology and leadership experience to drive innovation and strategic vision.

His past roles include SVP and Chairman of the POA at Caris Life Sciences, VP and CMO at Cardinal Health Specialty Solutions, and EVP and CMO at Aptitude Health. Academically, he has served as an Associate Professor of Medicine and the Director of Outpatient Cancer Clinics at the University of Chicago, and before that, Chief of Oncology and Cancer Institute Medical Director at Advocate Lutheran General Hospital in Park Ridge, IL. Dr. Nabhan is an esteemed author, podcaster, and speaker, recognized for his contributions to medical oncology and clinical research.

Alex Verbitsky

Vice President, AI and Data Science

Read more Close

Alex Verbitsky leads the AI and Data Science team at Ryght, building agentic production systems that accelerate clinical trials. With over eight years of experience spanning startups, government, and pharmaceutical companies, he has shipped multimodal AI systems for trial operations, document processing, data harmonization, and diagnostic imaging. Author of 10+ publications bridging AI and biomedicine, Alex holds an M.S. in Computer Science from Georgia Tech and a B.S. in Biomedical Engineering from Penn State.

Sara Dada

Senior Director of Product

Read more Close

Sara Dada is an experienced Product Management professional based in the San Francisco Bay Area. She has previously served on the product team of a B2B SaaS company, consulted for various startups, and worked as a data analyst for a venture fund. She studied Business Administration and Technology Ethics at Cal Poly SLO.

Isabella Murrell

Senior Director of AI & Engineering

Read more Close

Isabella Murrell, Senior Director of AI and Engineering at Ryght, leads our international engineering team in building innovative health-tech solutions. With a foundation in biomedical engineering and machine learning, she bridges complex technical challenges to real-world patient impact while championing a people-first, collaborative culture.

Dylan Wallace

Director of Business Development

Read more Close

As Director of Business Development, Dylan leads Ryght’s efforts to build relationships with customers and generate new business. Coming from the CRO space, at IQVIA Biotech, he understands the needs of biotech clients as well as the nuances of the clinical trial landscape. Dylan studied Business Administration and International Affairs at the University of North Carolina Wilmington and still calls Wilmington his home. When he is not working, you can find him at the pickleball courts, on the golf course, traveling the world, or spending time with his family.

John Harvey

Business Development Executive

Read more Close

As a Business Development Executive, John brings more than 2 decades of success and driving growth across the life sciences and technology sectors. He has consistently ranked among top producers at companies serving trial sponsors of all sizes, and has built and led teams that exceeded targets and established lasting client partnerships.

John studied economics at the College of the Holy Cross, and has an MBA and Certificate in Clinical Research from Boston College. His experience gives him a deep understanding of both customer challenges and how to navigate the nuances of the clinical research landscape. When he's not working, he enjoys mentoring other salespeople, participating in his children's activities, and saltwater fishing.

Ariel Paradis

Director of Marketing

Read more Close

As Director of Marketing, Ariel leads brand and product marketing at Ryght, drawing on over ten years of experience in B2B healthcare and technology industries. She is dedicated to building impactful brands and go-to-market strategies that ultimately drive innovation in the clinical research space.

Tarek Sherif

Advisor

Read more Close

Tarek Sherif, former CEO and co-founder, Medidata Solutions & Ryght Advisor, co-founded Medidata Solutions in 1999, where he played a pivotal role in transforming clinical research by automating and digitizing trials through cloud-based solutions. Under his leadership, Medidata became the industry standard for clinical trial data management and analytics, by delivering leading edge technology along with customer centric services.

Sherif brings a wealth of experience and a proven track record in pioneering cloud-based solutions and automating clinical trials.

Kent Siri

Advisor

Read more Close

Kent Siri is an accomplished B2B healthcare marketing leader with deep expertise in building standout brands, driving growth strategies, and developing high-performing teams. He currently serves as Vice President of Marketing at ZenQMS, where he helps life sciences companies streamline quality management with scalable SaaS solutions. Previously, Kent held senior marketing leadership roles at Reify Health, Medidata, SHYFT Analytics, and Kyruus, where he built brand foundations, led demand generation, and partnered with top life sciences organizations. He is passionate about creating customer-focused strategies that deliver measurable business impact.

Scientific Advisory Board

Ryght's Scientific Advisory Board (SAB) comprises globally recognized experts across oncology, hematology, dermatology, and Al who provide the clinical insights and strategic guidance needed to revolutionize how clinical trials are conducted worldwide.

LEARN MORE ABOUT THE SCIENTIFIC ADVISORY BOARD

Investors

Ryght's initial funding is supported by leading investors with a shared vision to improve healthcare by leveraging advances in AI technology. The initial round was led by Virtue with participation from AIX Ventures, Iaso Ventures, Page One Ventures, Top Harvest Capital, and additional strategic angel investors.

Partners

We understand that the foundation of transformative life sciences solutions rests on cutting-edge technology, robust security, and infinite scalability. To ensure our customers experience unparalleled success, we strategically partner with the industry’s leading technology and cloud service providers. Our meticulously selected network of partners empowers us to deliver secure, scalable, and cutting-edge AI-driven solutions tailored for the unique challenges of the life sciences sector.

KEEP UP WITH RYGHT

Stay Connected

Subscribe to be the first to know about product updates, news and announcements.